为探究抗 VEGF 治疗对单侧新生血管性年龄相关性黄斑变性（AMD）患者脉络膜厚度（CT）的影响，研究发现二者无显著差异，意义重大。 ### 探索抗 VEGF 治疗与脉络膜厚度关系：为 AMD 治疗解疑 在眼科疾病领域，年龄相关性黄斑变性（Age-related macular degeneration ...

为探究临床试验疾病活动标准对 nAMD 抗 VEGF 注射间隔的影响，研究发现两者差异显著，影响治疗决策。 # 临床试验疾病活动标准如何影响湿性年龄相关性黄斑变性治疗？ 在眼科疾病领域，年龄相关性黄斑变性（AMD）就像一个隐藏在暗处的 “视力杀手 ...

3月12日，哈医大二院眼科为一位在华探亲的患有年龄相关性黄斑变性（AMD）的美籍患者完成抗VEGF治疗跨国注射，这一跨国医疗案例凸显了哈医大二院眼科在眼底病诊疗领域的国际标准化水平。米切尔（Mitchell）今年72岁，长居美国加州，此前被确诊为新生血管性AMD，需要接受每6周一次的定期规范化玻璃体抗VEGF药物注射治疗。此次 ...

Clearside Biomedical (CLSD) announced that presentations on the Company’s lead clinical program, CLS-AX in neovascular age-related macular ...

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

Macular degeneration, particularly age-related macular degeneration (AMD), is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, ...

Wet AMD and diabetic macular edema are caused by excessive VEGF signaling, which causes abnormal blood vessel growth and leakage in the retina, leading to vision impairment. Anti-VEGF injections ...

Obstructive sleep apnea is associated with higher rates of age-related macular degeneration development and progression.

Novel drug that inhibits both VEGF-A and Angiopoietin -2 have a promising role in management of wet AMD. Can we lower the risk of getting AMD? Embrace a healthier lifestyle to reduce the risk of ...

In the randomized, sham-controlled ARTEMIS study, patients will receive either a dose of ixo-vec or a standard care regimen of anti-VEGF Eylea.

Baseline angiographic lesion characteristics predictive of clinical responsePublished in peer-reviewed journal Ophthalmic Surgery, Lasers and ...

Anti-VEGF therapy improves outcomes in retinal diseases by targeting neovascularization and macular edema, crucial in conditions like AMD and diabetic retinopathy. Optical coherence tomography is ...